198 related articles for article (PubMed ID: 32254065)
21. CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.
Luo X; Mo J; Zhang M; Huang W; Bao Y; Zou R; Yao L; Yuan L
World J Surg Oncol; 2024 Feb; 22(1):44. PubMed ID: 38317230
[TBL] [Abstract][Full Text] [Related]
22. RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.
Yang X; Pan Y; Qiu Z; Du Z; Zhang Y; Fa P; Gorityala S; Ma S; Li S; Chen C; Wang H; Xu Y; Yan C; Ruth K; Ma Z; Zhang J
Clin Cancer Res; 2018 Apr; 24(7):1629-1643. PubMed ID: 29326282
[No Abstract] [Full Text] [Related]
23. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
Ma Z; Wang X; He J; Xia J; Li Y
PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
[TBL] [Abstract][Full Text] [Related]
25. Role of hsa‑miR‑105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer.
Li M; Zhang S; Ma Y; Yang Y; An R
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33846814
[TBL] [Abstract][Full Text] [Related]
26. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
Xu JH; Wang Y; Xu D
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of lncRNA ASMTL-AS1 in Epithelial Ovarian Cancer Correlates with Worse Prognosis and Cancer Progression.
Xu H; Tang Y; Liu L; Yan J; Qin L
Horm Metab Res; 2022 Jul; 54(7):481-488. PubMed ID: 35835145
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma.
Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X
Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788
[TBL] [Abstract][Full Text] [Related]
29. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin-specific protease 14 (USP14) regulates cellular proliferation and apoptosis in epithelial ovarian cancer.
Wang Y; Wang J; Zhong J; Deng Y; Xi Q; He S; Yang S; Jiang L; Huang M; Tang C; Liu R
Med Oncol; 2015 Jan; 32(1):379. PubMed ID: 25429837
[TBL] [Abstract][Full Text] [Related]
31. CircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer.
Liu N; Zhang J; Zhang LY; Wang L
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3713-3718. PubMed ID: 29949144
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA‑193a‑5p exerts a tumor suppressive role in epithelial ovarian cancer by modulating RBBP6.
Zhang S; Liu J; He J; Yi N
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34132380
[TBL] [Abstract][Full Text] [Related]
33. DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells.
Zhang L; Zhang S; Li A; Zhang A; Zhang S; Chen L
Int J Mol Med; 2018 Dec; 42(6):3065-3072. PubMed ID: 30221689
[TBL] [Abstract][Full Text] [Related]
34. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
[TBL] [Abstract][Full Text] [Related]
35. Increased PTOV1 expression is related to poor prognosis in epithelial ovarian cancer.
Guo F; Feng L; Hu JL; Wang ML; Luo P; Zhong XM; Deng AM
Tumour Biol; 2015 Jan; 36(1):453-8. PubMed ID: 25270739
[TBL] [Abstract][Full Text] [Related]
36. The down-regulation of long non-coding RNA LINC01088 is associated with the poor prognosis of epithelial ovarian cancer patients.
Ai H; Xie W; Xiu AH; Li N; Zhang ST; Zhang YL; Xue XO
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5836-5841. PubMed ID: 30280763
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
38. [Expression of lnc-MyD88 and its relationship with the prognosis of patients with epithelial ovarian cancer].
Zhu Y; Huang JM; Zhang GN; Li JM; Huang J
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):117-124. PubMed ID: 35184472
[No Abstract] [Full Text] [Related]
39. Circ-ITCH correlates with small tumor size, decreased FIGO stage and prolonged overall survival, and it inhibits cells proliferation while promotes cells apoptosis in epithelial ovarian cancer.
Luo L; Gao Y; Sun X
Cancer Biomark; 2018; 23(4):505-513. PubMed ID: 30347599
[TBL] [Abstract][Full Text] [Related]
40. Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer.
Han GH; Chay DB; Nam S; Cho H; Chung JY; Kim JH
BMC Cancer; 2019 Dec; 19(1):1202. PubMed ID: 31823759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
